簡(jiǎn)介:Cetirizine DiHCl是hydroxyzine的主要代謝產(chǎn)物,是外消旋的選擇性H1受體反向激動(dòng)劑。
Cetirizine DiHCl物理化學(xué)性質(zhì):
密度 |
1.237 g/cm3 |
沸點(diǎn) |
542.1oC at 760 mmHg |
熔點(diǎn) |
110-115oC |
分子式 |
C21H27Cl3N2O3 |
分子量 |
461.81 |
閃點(diǎn) |
281.6oC |
PSA |
53.01 |
LogP |
3.826 |
外觀性狀 |
固體;White to Almost white powder to crystal |
儲(chǔ)存條件 |
Desiccate at RT |
Cetirizine DiHCl詳細(xì)介紹:
中文名稱: |
鹽酸西替利嗪 |
中文別名: |
鹽酸西替利嗪;(+/-)-2-[2-[4-[(4-氯苯基)苯甲基]-1-哌嗪基]乙氧基]乙酸二鹽酸鹽;二鹽酸西替利嗪;西替利嗪;西替利嗪-D4;西替利嗪丁二鹽酸鹽;鹽酸西替利嗪 EP標(biāo)準(zhǔn)品;鹽酸西替利嗪 USP標(biāo)準(zhǔn)品;鹽酸西替利嗪 標(biāo)準(zhǔn)品;鹽酸西替利嗪 雜質(zhì)對(duì)照品;鹽酸西替利嗪(cetirizine)雜質(zhì)對(duì)照品;鹽酸鹽西替利嗪 標(biāo)準(zhǔn)品;(±)-2-[2-[4-[(4-氯苯基)苯甲基]-1-哌嗪基]乙氧基]乙酸二鹽酸鹽;西替利嗪鹽酸鹽;[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid 二鹽酸鹽 |
英文名稱: |
Cetirizine hydrochloride |
英文別名: |
2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride;Cetrizine Di-HCl;Cetirizine Hydrochloride;2-(2-{4-[(4-Chlorophenyl)(phenyl)-methyl]piperazino}ethoxy)acetic acid dihydrochloride;Cetirizine dihydrochloride;2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid,dihydrochloride;Cetirizine DiHCl;Cetirizine Dihydrochloride(UCB P071, Virlix?, Reactine?, Zyrtec?);Cetrizide;P 071;P-071;Virlix;Zyrtec?;Levocetirizine dihydrochloride;Zyrtec;Reactine;Alerlisin;Stopaler;Ressital;Cetriler;Alergex;Alercet;Zyrzine;Formistin;Cetzine;Alertisin;Setiral;Salvalerg;Cetrine;Zirtin;Alerid;Virdos;Riztec;Ryzen;Cezin;Triz;Xero-sed;Cetirizine HCl;Children's Zyrtec;Cetirizine (dihydrochloride);Zerviate;Cetirizine 2HCl;Cetirigamma;Voltric;Ceterifug;Cetale |
CAS號(hào): |
83881-52-1 |
分子式: |
C21H27CL3N2O3 |
分子量: |
461.81 |
詳細(xì)描述 |
博飛美科提供83881-52-1,Cetirizine DiHCl,Medlife,上海現(xiàn)貨。 Medlife,致力于提供高品質(zhì)、高性價(jià)比小分子化合物的產(chǎn)品。 Medlife小分子化合物大量庫(kù)存,提供超過2萬種的抑制劑、激動(dòng)劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應(yīng)商。 H1受體反向激動(dòng)劑,Cetirizine二鹽酸鹽是第二代抗組胺劑,是hydroxyzine的主要代謝產(chǎn)物,是外消旋的選擇性H1受體反向激動(dòng)劑。 查詢關(guān)鍵詞:“83881-52-1,Cetirizine DiHCl,PC14196,Medlife,上?,F(xiàn)貨”。 |
Cetirizine DiHCl參考文獻(xiàn):
[1]. Naclerio RM. Additional properties of cetirizine, a new H1 antagonist. Allergy Proc. 1991 May-Jun;12(3):187-91.
[2]. Meh A, et al. Effect of cetirizine, a histamine (H(1)) receptor antagonist, on bone modeling during orthodontic tooth movement in rats. Am J Orthod Dentofacial Orthop. 2011 Apr;139(4):e323-9.
產(chǎn)品技術(shù)規(guī)格說明書由上海創(chuàng)賽科技有限公司收集整理,僅作參考使用。